Form 4: TD SYNNEX Director Sells Shares After Option Exercise

TD SYNNEX Director Richard T. Hume exercised stock options and subsequently sold a portion of his shares under a pre-arranged 10b5-1 trading plan.

Summary

• Director Richard T. Hume exercised 18,365 employee stock options for TD SYNNEX Corp (SNX) common stock at an exercise price of $107.32 per share.
• Following the exercise, Hume sold a total of 23,365 shares of common stock in multiple transactions.
• The sales occurred at weighted average prices ranging from $157.66 to $161.18 per share.
• All transactions were executed on February 2, 2026, under a Rule 10b5-1 trading plan adopted on July 14, 2025.
• After these transactions, Hume's direct beneficial ownership of TD SYNNEX common stock stands at 42,515 shares.
• The exercised stock option was fully vested.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While a director selling shares can sometimes be a slight negative, the pre-planned nature via a 10b5-1 plan and the exercise of vested options make it a routine compensation-related transaction rather than a signal of company distress.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent approach to share disposition.
• The sales occurred at prices significantly higher than the option exercise price, indicating a profitable transaction for the director.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, suggesting a lack of conviction or a desire to diversify.
• The director's beneficial ownership decreased by 5,000 shares (18,365 acquired 23,365 sold) from his initial holding before the transactions.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is solely focused on insider trading activity.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common occurrences for executives and directors managing their personal portfolios. While the sale of shares by a director might sometimes be viewed with caution, the pre-arranged nature of a 10b5-1 plan typically mitigates concerns about opportunistic selling based on non-public information. This transaction reflects a director monetizing vested options, a routine part of executive compensation.

Comparison to Industry Standards

• This Form 4 filing details a standard insider transaction involving the exercise of vested stock options and subsequent sale of shares. Such transactions are common across all industries for executives and directors managing their equity compensation.
• There are no specific comparable companies or projects mentioned in this filing to benchmark against, as it focuses on an individual's trading activity rather than company performance or project outcomes.
• The use of a 10b5-1 plan aligns with best practices for insider trading compliance, similar to how executives at companies like Apple (AAPL) or Microsoft (MSFT) manage their equity compensation.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be interpreted in various ways, but the 10b5-1 plan mitigates concerns of opportunistic selling. The overall impact on share price is likely minimal unless the volume is unusually large or the timing is suspicious.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction where a director exercised vested stock options and subsequently sold a portion of their shares under a pre-arranged 10b5-1 trading plan. Such transactions are common for executive compensation and do not typically signal a fundamental change in the company's prospects. While the sale reduces the director's direct ownership, the pre-planned nature suggests it's not based on new, negative material information. Therefore, the filing itself does not provide sufficient new information to warrant a change from a 'hold' recommendation, as it's a personal financial management event rather than a corporate performance indicator.

Keywords

TD SYNNEX, SNX, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, 10b5-1 Plan